IVC Wealth Advisors LLC decreased its position in shares of The Clorox Company (NYSE:CLX – Free Report) by 9.5% in the 4th quarter, HoldingsChannel.com reports. The fund owned 2,522 shares of the company’s stock after selling 265 shares during the quarter. IVC Wealth Advisors LLC’s holdings in Clorox were worth $410,000 as of its most recent filing with the SEC.
Several other institutional investors have also modified their holdings of CLX. Avior Wealth Management LLC raised its holdings in shares of Clorox by 17.7% during the fourth quarter. Avior Wealth Management LLC now owns 1,209 shares of the company’s stock valued at $196,000 after buying an additional 182 shares during the last quarter. Independent Wealth Network Inc. boosted its position in Clorox by 7.2% during the 4th quarter. Independent Wealth Network Inc. now owns 4,264 shares of the company’s stock worth $692,000 after acquiring an additional 287 shares during the period. Janney Montgomery Scott LLC boosted its position in Clorox by 7.9% during the 4th quarter. Janney Montgomery Scott LLC now owns 109,275 shares of the company’s stock worth $17,747,000 after acquiring an additional 7,983 shares during the period. SG Americas Securities LLC grew its stake in shares of Clorox by 489.2% in the fourth quarter. SG Americas Securities LLC now owns 115,252 shares of the company’s stock worth $18,718,000 after purchasing an additional 95,691 shares in the last quarter. Finally, Eads & Heald Wealth Management increased its holdings in shares of Clorox by 2.3% during the fourth quarter. Eads & Heald Wealth Management now owns 8,129 shares of the company’s stock valued at $1,320,000 after purchasing an additional 180 shares during the period. Institutional investors own 78.53% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of equities analysts recently issued reports on CLX shares. JPMorgan Chase & Co. increased their target price on shares of Clorox from $167.00 to $171.00 and gave the company a “neutral” rating in a research report on Thursday, January 16th. Evercore ISI lowered their price objective on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a research note on Monday, October 14th. DA Davidson boosted their target price on Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a report on Monday, November 4th. Wells Fargo & Company raised Clorox from an “underweight” rating to an “equal weight” rating and increased their price target for the company from $155.00 to $157.00 in a research note on Tuesday, January 7th. Finally, TD Cowen upgraded Clorox from a “sell” rating to a “hold” rating and upped their price objective for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. Four analysts have rated the stock with a sell rating, ten have given a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, Clorox currently has an average rating of “Hold” and a consensus price target of $156.54.
Clorox Price Performance
NYSE CLX opened at $160.81 on Friday. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37. The stock’s 50-day moving average price is $163.93 and its two-hundred day moving average price is $157.11. The company has a market cap of $19.90 billion, a PE ratio of 56.03, a PEG ratio of 2.95 and a beta of 0.42. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08.
Clorox (NYSE:CLX – Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The business had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same quarter in the previous year, the business earned $0.49 earnings per share. The firm’s revenue was up 27.0% compared to the same quarter last year. On average, analysts predict that The Clorox Company will post 6.87 EPS for the current year.
Clorox Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be issued a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.03%. Clorox’s dividend payout ratio is 170.04%.
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Articles
- Five stocks we like better than Clorox
- Want to Profit on the Downtrend? Downtrends, Explained.
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- The 3 Best Retail Stocks to Shop for in August
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- What is the MACD Indicator and How to Use it in Your Trading
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.